We are pleased to announce Felipe Mesquita as the new partner of Licks Attorneys, further expanding our expertise in complex litigation before Brazilian trial and appellate courts. He is also well versed in administrative proceedings before government agencies, such as the Brazilian FDA (ANVISA) and the Brazilian PTO (INPI). Mr. Mesquita expertise comprises a wide […]
New pricing guidelines for biosimilars issued by the Brazilian regulatory authorities without an opportunity for public comments reachesthe market with con icting statements.IntroductionOn August 11, 2016, the Brazilian Pharmaceutical Market Regulation Chamber (CMED) issued Notice #9/2016, which established the pricing criteria for biological products approved by the Brazilian Food and Drug Administration (BRFDA) through abbreviated […]
It took the Brazilian Food and Drug Administration (ANVISA) 13 years to update its rules on over-the-counter status requirements and proceduresIntroductionOn August 3, 2016, the ANVISA issued Rule #98 of 2016, containing the administration’s new guidelinesfor a drug to obtain the OTC status, which allows it to be sold without a medical prescription.This rule revokes […]
(BRPTO Official Gazette #2,377, of July 26, 2016)The BRPTO published today, July 26, 2016, the awaited Rule #169/2016 implementing the guidelines for the examination of patent applications on patentability requirements (Block II of the Patent Examination Guidelines).The BRPTO has issued three guidelines for the examination of patent applications.On April 2013, the BRPTO published Rule #85/2013, […]
Brazilian law firm Licks Attorneys has hired Antonio Morschbacker as a patent specialist in the firm’s patent group in Rio de Janeiro.Morschbacker joins from Morschbacker Consulting, a firm he founded and worked at as a partner. He has also worked at petrochemical company Braskem as renewable technologies director.He has experience as an inventor and co-inventor […]
